Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carmelia Maria Noia Barreto
Cost-Effectiveness Analysis of Abiraterone, Docetaxel or Placebo Plus Androgen Deprivation Therapy for Hormone-Sensitive Advanced Prostate Cancer
Einstein (São Paulo, Brazil)
Medicine
Related publications
Abiraterone Acetate and Docetaxel With Androgen Deprivation Therapy in High-Volume Metastatic Hormone-Sensitive Prostate Cancer in China: An Indirect Treatment Comparison and Cost Analysis
Cost Effectiveness and Resource Allocation
Health Policy
Comparative Effectiveness of Radical Prostatectomy With Adjuvant Radiotherapy Versus Radiotherapy Plus Androgen Deprivation Therapy for Men With Advanced Prostate Cancer
Cancer
Cancer Research
Oncology
Androgen Deprivation Therapy for Prostate Cancer
Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Decision Analytic Cost-Effectiveness Model to Compare Prostate Cryotherapy to Androgen Deprivation Therapy for Treatment of Radiation Recurrent Prostate Cancer
BMJ Open
Medicine
Medical Resource Utilization of Abiraterone Acetate Plus Prednisone Added to Androgen Deprivation Therapy in Metastatic Castration-Naive Prostate Cancer: Results From LATITUDE
Cancer
Cancer Research
Oncology
Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia
BJU International
Urology
Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Re: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer
European Urology
Urology
